ProShare Advisors
PRNB

ProShare Advisors’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

ProShare Advisors’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,275
Closed -$555K – 1712
2020
Q2 		$555K Buy
9,275
+3,681
+66% +$227K ﹤0.01% 905
2020
Q1 		$332K Sell
5,594
-3,989
-42% -$233K ﹤0.01% 847
2019
Q4 		$525K Buy
+9,583
New +$358K ﹤0.01% 1041

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

ProShare Advisors's PRNB Position: Q3 2020 in Review

ProShare Advisors sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 9,275 shares — an estimated $555K sold.

ProShare Advisors first reported a position in PRNB in Q4 2019 and held it in 3 quarters. The position peaked at $555K in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • ProShare Advisors reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • ProShare Advisors sold 9,275 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $555K.
  • ProShare Advisors first reported a position in Principia Biopharma Inc. Common Stock in Q4 2019 and held it in 3 quarters.
  • ProShare Advisors's Principia Biopharma Inc. Common Stock position peaked at $555K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on ProShare Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.